{"abstract": "DaVita, a dialysis chain, has agreed to make major purchases of Epogen, the Amgen drug, to help the manufacturer as it faces new competition.", "web_url": "https://www.nytimes.com/2011/11/19/business/deal-assures-market-for-anemia-drug.html", "snippet": "DaVita, a dialysis chain, has agreed to make major purchases of Epogen, the Amgen drug, to help the manufacturer as it faces new competition.", "lead_paragraph": "Moving to protect a lucrative monopoly against impending competition, Amgen has reached an agreement that will preserve its status as the main supplier of anemia drugs to one of the nation\u2019s two large kidney dialysis chains. ", "source": "The New York Times", "multimedia": [], "headline": {"main": "Deal Assures Market for Anemia Drug", "kicker": null, "content_kicker": null, "print_headline": "Deal Assures Market for Anemia Drug", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": 1, "major": "N"}, {"name": "subject", "value": "ANEMIA", "rank": 2, "major": "N"}, {"name": "organizations", "value": "DaVita Inc", "rank": 3, "major": "N"}, {"name": "organizations", "value": "AMGEN INC", "rank": 4, "major": "N"}, {"name": "subject", "value": "Generic Brands and Products", "rank": 5, "major": "N"}, {"name": "subject", "value": "Antitrust Laws and Competition Issues", "rank": 6, "major": "N"}], "pub_date": "2011-11-18T17:32:25+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Andrew Pollack", "person": [{"firstname": "Andrew", "middlename": null, "lastname": "Pollack", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/62192643-9d22-5ddb-a1a7-1c7b2ba515a5", "word_count": 406, "uri": "nyt://article/62192643-9d22-5ddb-a1a7-1c7b2ba515a5"}